Zygene Biotechnologies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 138.57%
- Profit Growth 43.98%
- Ebitda 58.29%
- Net Worth -33.34%
- Total Assets 505.78%
About Zygene Biotechnologies
Zygene Biotechnologies Private Limited (ZBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 24 June 2019 (Five years and seven months 9 days old ). Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rishad Kalappurakkal and Nasiya Aliyar serve as directors at the Company.
Company Details
-
Location
Ernakulam, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85100KL2019PTC058542
-
Company No.
058542
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Jun 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
What products or services does Zygene Biotechnologies Private Limited offer?
Zygene Biotechnologies Private Limited offers a wide range of products and services, including Research and Development (R&D) Work, Product Development Research.
Who are the key members and board of directors at Zygene Biotechnologies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rishad Kalappurakkal
|
Director | 24-Jun-2019 | Current |
|
Nasiya Aliyar
|
Director | 24-Jun-2019 | Current |
Financial Performance of Zygene Biotechnologies.
Zygene Biotechnologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 138.57% increase. The company also saw a substantial improvement in profitability, with a 43.98% increase in profit. The company's net worth observed a substantial decline by a decrease of 33.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zygene Biotechnologies?
Unlock access to Zygene Biotechnologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Klonos Life Sciences Private LimitedRishad Kalappurakkal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zygene Biotechnologies?
Unlock and access historical data on people associated with Zygene Biotechnologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zygene Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zygene Biotechnologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.